Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy
Publication type: Journal Article
Publication date: 2016-04-20
scimago Q2
wos Q3
SJR: 0.610
CiteScore: 6.4
Impact factor: 3.3
ISSN: 15680266, 18734294
PubMed ID:
27086790
Drug Discovery
General Medicine
Abstract
Imidazo[1,2-a]pyridine has been shown to be an important biologically active moiety. This review is a compilation of the scattered output of results of the anticancer activities of the imidazo[1,2-a]pyridine system since 2001, which have been classified as inhibition of CDK, VEGFR, PI3K, EGFR, RGGT etc. along with inhibition against different tumor cell lines. Various imidazo[1,2-a]pyridine based analogues have been used as lead molecules and are now under human clinical trials. This review will help the wider scientific community in the area of drug discovery of imidazo[1,2-a]pyridines as novel anticancer agents.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Journal of Organic Chemistry
5 publications, 5.21%
|
|
|
Tetrahedron Letters
5 publications, 5.21%
|
|
|
Organic and Biomolecular Chemistry
5 publications, 5.21%
|
|
|
Beilstein Journal of Organic Chemistry
4 publications, 4.17%
|
|
|
Journal of Molecular Structure
3 publications, 3.13%
|
|
|
Tetrahedron
3 publications, 3.13%
|
|
|
Asian Journal of Organic Chemistry
3 publications, 3.13%
|
|
|
Advanced Synthesis and Catalysis
3 publications, 3.13%
|
|
|
Green Chemistry
3 publications, 3.13%
|
|
|
New Journal of Chemistry
3 publications, 3.13%
|
|
|
European Journal of Organic Chemistry
3 publications, 3.13%
|
|
|
Bioorganic and Medicinal Chemistry
2 publications, 2.08%
|
|
|
Chemistry - An Asian Journal
2 publications, 2.08%
|
|
|
RSC Advances
2 publications, 2.08%
|
|
|
Heterocycles
2 publications, 2.08%
|
|
|
Synthesis
2 publications, 2.08%
|
|
|
Current Organic Chemistry
2 publications, 2.08%
|
|
|
ChemistrySelect
2 publications, 2.08%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 1.04%
|
|
|
Acta Crystallographica Section E: Crystallographic Communications
1 publication, 1.04%
|
|
|
Oncology Letters
1 publication, 1.04%
|
|
|
MolBank
1 publication, 1.04%
|
|
|
Catalysts
1 publication, 1.04%
|
|
|
Frontiers in Pharmacology
1 publication, 1.04%
|
|
|
Frontiers in Chemistry
1 publication, 1.04%
|
|
|
Apoptosis : an international journal on programmed cell death
1 publication, 1.04%
|
|
|
Molecular Diversity
1 publication, 1.04%
|
|
|
Green Synthesis and Catalysis
1 publication, 1.04%
|
|
|
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
1 publication, 1.04%
|
|
|
Catalysis Communications
1 publication, 1.04%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
22 publications, 22.92%
|
|
|
Wiley
21 publications, 21.88%
|
|
|
Royal Society of Chemistry (RSC)
14 publications, 14.58%
|
|
|
Springer Nature
7 publications, 7.29%
|
|
|
American Chemical Society (ACS)
6 publications, 6.25%
|
|
|
Beilstein-Institut
4 publications, 4.17%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 3.13%
|
|
|
MDPI
3 publications, 3.13%
|
|
|
Georg Thieme Verlag KG
3 publications, 3.13%
|
|
|
Frontiers Media S.A.
2 publications, 2.08%
|
|
|
The Japan Institute of Heterocyclic Chemistry
2 publications, 2.08%
|
|
|
Taylor & Francis
2 publications, 2.08%
|
|
|
International Union of Crystallography (IUCr)
1 publication, 1.04%
|
|
|
Spandidos Publications
1 publication, 1.04%
|
|
|
Pleiades Publishing
1 publication, 1.04%
|
|
|
Centre for Evaluation in Education and Science (CEON/CEES)
1 publication, 1.04%
|
|
|
EDP Sciences
1 publication, 1.04%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 1.04%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
96
Total citations:
96
Citations from 2024:
27
(28%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Paul K. Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy // Current Topics in Medicinal Chemistry. 2016. Vol. 16. No. 30. pp. 3590-3616.
GOST all authors (up to 50)
Copy
Paul K. Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy // Current Topics in Medicinal Chemistry. 2016. Vol. 16. No. 30. pp. 3590-3616.
Cite this
RIS
Copy
TY - JOUR
DO - 10.2174/1568026616666160414122644
UR - https://doi.org/10.2174/1568026616666160414122644
TI - Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy
T2 - Current Topics in Medicinal Chemistry
AU - Paul, Kamaldeep
PY - 2016
DA - 2016/04/20
PB - Bentham Science Publishers Ltd.
SP - 3590-3616
IS - 30
VL - 16
PMID - 27086790
SN - 1568-0266
SN - 1873-4294
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2016_Goel,
author = {Kamaldeep Paul},
title = {Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy},
journal = {Current Topics in Medicinal Chemistry},
year = {2016},
volume = {16},
publisher = {Bentham Science Publishers Ltd.},
month = {apr},
url = {https://doi.org/10.2174/1568026616666160414122644},
number = {30},
pages = {3590--3616},
doi = {10.2174/1568026616666160414122644}
}
Cite this
MLA
Copy
Goel, Richa, et al. “Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy.” Current Topics in Medicinal Chemistry, vol. 16, no. 30, Apr. 2016, pp. 3590-3616. https://doi.org/10.2174/1568026616666160414122644.